100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Tirzepatide is a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It enhances glucose-dependent insulin secretion, suppresses glucagon secretion, delays gastric emptying, and promotes satiety. These actions collectively contribute to improved glycemic control and weight reduction.
Treat type 2 diabetes
Initial Dose:
Start with 2.5 mg subcutaneously once weekly for 4 weeks.
Titration: Increase by 2.5 mg increments every 4 weeks as tolerated.
Maximum dose: 15 mg once weekly.
Administration Instructions:
Missed Dose:
If a dose is missed, administer within 4 days. If more than 4 days have passed, skip and resume the regular schedule.
Common:
Serious:
Hormonal Contraceptives (e.g., Desogestrel, Drospirenone, Levonorgestrel)
Tirzepatide may reduce oral contraceptive efficacy.
Warfarin
May alter INR; monitor closely.
Other Antidiabetics:
Risk of hypoglycemia when used with sulfonylureas or insulin. Monitor glucose levels and adjust dose if needed.
Alcohol: Increases risk of hypoglycemia.
Food: Can be administered with or without food.
Smoking: No specific interactions documented, but lifestyle factors may impact glycemic control.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.